Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 12, 2007. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares in accordance with shareholder authority granted at the Annual General Meeting on May 17, 2006.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the share repurchase price of 1,423.4284 pence per share.
Material Changes
- Share Repurchase: On April 12, 2007, the company purchased 500,000 ordinary shares of 25 pence each.
- Treasury Holdings: Following this transaction, the total number of shares held in Treasury increased to 285,192,678.
- Shares in Issue: The total number of shares in issue (excluding Treasury shares) stands at 5,725,757,849.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities.
Investor Verification Points
- Verify the total Treasury share count of 285,192,678 against subsequent filings.
- Confirm the total voting rights denominator of 5,725,757,849 for disclosure threshold calculations under Financial Services Authority rules.
- Note that this filing is a transactional report and does not reflect the company's broader financial performance for the period.